<DOC>
	<DOCNO>NCT00459732</DOCNO>
	<brief_summary>The purpose study test whether zinc improve bone health young patient thalassemia .</brief_summary>
	<brief_title>Zinc &amp; Bone Health Thalassemia : The Think Zinc Study</brief_title>
	<detailed_description>The primary aim study determine zinc supplementation improve bone health young patient thalassemia . Osteoporosis significant co-morbidity patient thalassemia lead decrease quality life . The effective way prevent osteoporosis build strong , dense bone early year . A combination disease , endocrine nutritional factor likely contribute etiology osteoporosis population . However , even well transfused patient normal gonadal function supplement calcium low bone mass . It hypothesize patient thalassemia low bone mass , part , due zinc deficiency . Sub-optimal zinc status identify patient thalassemia zinc supplementation show improve linear growth . To test primary hypothesis , 18 month randomize placebo-controlled trial zinc supplementation ( 25 mg Zn/day ) vs. placebo conduct 60 young patient ( 6-30 yr ) thalassemia low bone mass ( spine BMD Z-score &lt; -1.0 ) . Bone health , estimate measurement bone mass ( DXA pQCT ) marker bone formation resorption primary outcome variable . This first study examine effect zinc supplementation bone health patient thalassemia . If zinc supplementation find clinically important effect , simple , safe , non-invasive therapy could quickly become part standard care young patient improve overall health child adult patient thalassemia</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Zinc Sulfate</mesh_term>
	<criteria>6 30 year age thalassemia bone mineral density Zscore &lt; 1.0 ( DXA ) Bone marrow transplant recipient Currently prescribe treatment low bone mass calcium vitamin D ( e.g . calcitonin , bisphosphonates ) Currently prescribe zinc supplementation unable unwilling stop trial Currently participate another trial medication know affect bone mineral density . Chronic use systemic corticosteroid Untreated hypogonadism growth hormone deficiency Baseline serum copper &lt; 70 Âµg/dL Baseline vitamin D25OH &lt; 11 ng/mL Pregnant lactating study entry</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>zinc , thalassemia , bone mineral density</keyword>
</DOC>